NEWRON PHARMACEUTICALS SPA (NP5.DE) Stock Earnings Estimates
Europe • Frankfurt Stock Exchange • FRA:NP5 • IT0004147952
21.7 EUR
-0.3 (-1.36%)
Last: Jan 30, 2026, 07:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.094M 5.76% | 9.057M 48.62% | 51.39M 467.41% | 17.886M -65.20% | 14.512M -18.86% | 14.244M -1.85% | 184.49M 1,195.21% | 142.3M -22.87% | 193.12M 35.71% | 259.7M 34.48% | 326.78M 25.83% | 354.74M 8.56% | |
| EBITDA YoY % growth | -13.1M -7.84% | -11.428M 12.76% | 26.365M 330.71% | -17.976M -168.18% | -19.543M -8.72% | -7.268M 62.81% | 152.36M 2,196.46% | 173.66M 13.98% | 160.38M -7.65% | 201.25M 25.48% | 226.78M 12.69% | 243.13M 7.21% | |
| EBIT YoY % growth | -13.302M -7.65% | -11.629M 12.58% | 26.173M 325.07% | -13.391M -151.16% | -20.471M -52.87% | -7.931M 61.26% | 152.36M 2,021.19% | 173.66M 13.98% | 160.38M -7.65% | 201.25M 25.48% | 226.78M 12.69% | 242.11M 6.76% | |
| Operating Margin | -218.28% | -128.40% | 50.93% | -74.87% | -141.06% | -55.68% | 82.58% | 122.04% | 83.05% | 77.49% | 69.40% | 68.25% | |
| EPS YoY % growth | -0.98 -16.67% | -0.91 7.14% | 0.85 193.41% | -0.85 -200.56% | -0.99 -15.27% | -0.56 43.58% | 4.77 957.67% | 5.44 14.20% | 5.37 -1.31% | 6.80 26.62% | 7.54 10.81% | 8.52 13.01% |
All data in EUR
| Q4 / 25 | Q2 / 26 | Q4 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.67 -149.13% | -0.65 -16,220.00% | -0.73 -9.16% |
| Revenue Q2Q % growth | 3.876M -91.92% | 8.058M -32.27% | 9.18M 136.84% |
| EBITDA Q2Q % growth | -11.383M -133.43% | 1.459M 124.92% | N/A |
| EBIT Q2Q % growth | -11.483M -133.92% | -6.403M -7.49% | -10.254M 10.70% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.00 99.22% | -0.45 | 0.44 | 99.11% |
| Q4 2024 Q2Q % growth | 1.36 361.54% | 1.95 | -0.59 | -30.19% |
| Q2 2024 Q2Q % growth | -0.51 -30.77% | -0.51 | 0.00 | 0.00% |
| Q4 2023 Q2Q % growth | -0.52 -4.00% | -0.50 | -0.02 | -4.04% |
| Q2 2023 Q2Q % growth | -0.39 18.75% | -0.58 | 0.19 | 32.92% |
| Q4 2022 Q2Q % growth | -0.50 -51.52% | -0.54 | 0.04 | 7.51% |
| Q2 2022 Q2Q % growth | -0.48 5.88% | -0.45 | -0.03 | -6.95% |
| Q4 2021 Q2Q % growth | -0.33 44.07% | -0.63 | 0.30 | 47.39% |
| Q2 2021 Q2Q % growth | -0.51 13.56% | -0.59 | 0.08 | 13.79% |
| Q4 2020 Q2Q % growth | -0.59 | -0.71 | 0.12 | 17.37% |
| Q2 2020 Q2Q % growth | -0.59 | -0.73 | 0.14 | 19.66% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 11.898M 249.22% | 9.119M | 2.779M | 30.47% |
| Q4 2024 Q2Q % growth | 47.983M 1,246.70% | 48.654M | -671K | -1.38% |
| Q2 2024 Q2Q % growth | 3.407M -37.99% | 3.672M | -265K | -7.22% |
| Q4 2023 Q2Q % growth | 3.563M 9.16% | 3.468M | 95K | 2.74% |
| Q2 2023 Q2Q % growth | 5.494M 94.13% | 3.264M | 2.23M | 68.32% |
| Q4 2022 Q2Q % growth | 3.264M 5.60% | 3.274M | -10K | -0.31% |
| Q2 2022 Q2Q % growth | 2.83M 5.95% | 3.264M | -434K | -13.30% |
| Q4 2021 Q2Q % growth | 3.091M 12.44% | 3.06M | 31K | 1.01% |
| Q2 2021 Q2Q % growth | 2.671M 6.46% | 2.55M | 121K | 4.75% |
| Q4 2020 Q2Q % growth | 2.749M | 2.958M | -209K | -7.07% |
| Q2 2020 Q2Q % growth | 2.509M | 2.856M | -347K | -12.15% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 23.35% |
| Revenue | N/A | N/A | 0% | 3.75% |